MAPT and psychiatric disorder: Additionally, concomitantly increased NfL levels and reduced phospho-tau/tau ratio in the CSF, and increased NfL levels in serum might show potential as biomarkers discriminating bvFTD from psychiatric disorders (Vijverberg et al., 2017; Al Shweiki et al., 2019).